GOAL.MD review
A named, checkable physician (Dr. Michael Mimlitz, MD) backs a $199/mo semaglutide, $299/mo tirzepatide standard rate — the ads lead with a $50-off first month, but the real ongoing number sits right on the same page.
then $199/mo ongoing
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
GOAL.MD at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Nationwide, per its own site
- Brand-name
- Yes
How we scored GOAL.MD
Each factor is scored from GOAL.MD's real pricing, disclosures and oversight, then combined into the 58/100 Editors' Rating by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Limited public detail on who oversees care and how.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- goal.md/weight-loss/semaglutide-injection
Independently live-verified 2026-08-04. Semaglutide page: "$149 your first month ($50 off), then $199/mo." Tirzepatide page: "$249 your first month ($50 off), then $299/mo." Both list a named, NPI-searchable physician. A brand-access page exists but publishes no price.
What to expect when you sign up
We walked GOAL.MD's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Each product page states the promo and standard price directly on one line
- 2Free consultation with a licensed U.S. physician
- 3Medications dispensed by licensed U.S. pharmacies
- 4Site states "No auto-billing" for the ongoing charge
What we noticed
- Medically reviewed by a named, NPI-verifiable physician: Dr. Michael Mimlitz, MD (NPI 1508891870)
- A dedicated brand-name-access page exists for manufacturer-channel medication, though no price is published there
- The ad copy leads with the first-month promo, not the standard rate — read past the first line
- No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $149 → $199 | Standard monthly"$149 your first month ($50 off), then $199/mo" — $199 is the standard ongoing rate. |
| Compounded tirzepatide | $249 → $299 | Standard monthly"$249 your first month ($50 off), then $299/mo" — same promo-then-standard structure. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect GOAL.MD's public disclosures at last review and change often; confirm the current number on GOAL.MD's own site.
What we like
- Names an NPI-verifiable physician rather than an anonymous clinical network
- The standard ongoing rate is disclosed on the same page as the promo
- Nationwide, plus a separate brand-name-access pathway
- States "No auto-billing" for the ongoing charge
The caveats
- Marketing leads with the promo rate, not the standard monthly price
- No price published for the brand-name-access pathway
- No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
GOAL.MD for mothers: our verdict
A named, checkable physician (Dr. Michael Mimlitz, MD) backs a $199/mo semaglutide, $299/mo tirzepatide standard rate — the ads lead with a $50-off first month, but the real ongoing number sits right on the same page. The advertised entry is $149, but the standing rate settles near $199/month — so read the headline as a starting offer, not the real monthly cost.
We weigh GOAL.MD the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the parts a generic weight-loss review skips.
What GOAL.MD actually costs
- Compounded semaglutide — Standard monthly: $149 to start, then $199/mo
- Compounded tirzepatide — Standard monthly: $249 to start, then $299/mo
For context, the typical ongoing price across our roster is around $155/month, so GOAL.MD sits at the premium end.
The medications GOAL.MD prescribes
GOAL.MD prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own pregnancy and lactation labeling, which is cleaner to hand to an OB.
Where GOAL.MD fits — and where it doesn't — for mothers
A good fit if…
- you want a real clinician reading your history around the real monthly cost once the dose climbs, not an auto-approving quiz.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence in GOAL.MD's public facts is high — pricing, pharmacies, and clinical network were verifiable at last review. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
GOAL.MD is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who want a real, checkable physician's name behind the prescription and don't mind reading past a promo headline.
Alternatives to GOAL.MD
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing GOAL.MD
Head-to-head & alternatives
GOAL.MD, answered
- Is $149/mo GOAL.MD's real price?
- No — that's the first-month promo. The page itself says "then $199/mo" for semaglutide going forward (and $249 then $299 for tirzepatide).
- Does GOAL.MD offer brand-name Wegovy or Zepbound?
- It has a dedicated brand-access page for manufacturer-channel medication, but no price is published there.
Pricing, states and verification reflect GOAL.MD's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.